NASDAQ:HPTX

(HPTX) (HPTX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
786,899 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HPTX stock logo

About (HPTX) Stock (NASDAQ:HPTX)

Horizon Therapeutics, Inc., formerly Hyperion Therapeutics, Inc., is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases. The Company's products include RAVICTI (glycerol phenylbutyrate) oral liquid, BUPHENYL and AMMONAPS (sodium phenylbutyrate) tablets and powder. The Company's products are used to lower ammonia in the blood. RAVICTI is used to treat urea cycle disorders (UCD). BUPHENYL is indicated as an adjunctive therapy in the chronic management of patients with UCDs involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS). The Company sells BUPHENYL under the brand name AMMONAPS in Europe and the Middle East.

HPTX Stock News Headlines

Never use this word on your phone (FBI could be watching)
This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...
Never use this word on your phone (FBI could be watching)
This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...
ESA confirms cancellation of E3 2023
These Are the 12 Best Picnic Spots in Dallas
This Week's Dallas Area Events
See More Headlines
Receive HPTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (HPTX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2015
Today
5/05/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:HPTX
CUSIP
44915N10
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

HPTX Stock Analysis - Frequently Asked Questions

How were (HPTX)'s earnings last quarter?

(HPTX) (NASDAQ:HPTX) released its quarterly earnings results on Thursday, February, 26th. The biopharmaceutical company reported $0.47 EPS for the quarter, beating analysts' consensus estimates of ($0.20) by $0.67. The biopharmaceutical company earned $30.80 million during the quarter, compared to analysts' expectations of $24.60 million. (HPTX)'s quarterly revenue was up 65.6% on a year-over-year basis.

What other stocks do shareholders of (HPTX) own?
This page (NASDAQ:HPTX) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners